Busulfan versus hydroxyurea in the treatment of polycythemia vera (PV) and essential thrombocythemia (ET)
Brodsky
I
I
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002066:Busulfan / Q000627:therapeutic use*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011087:Polycythemia Vera / Q000150:complications / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D013920:Thrombocythemia, Essential / Q000150:complications / Q000188:drug therapy*
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D002066:Busulfan; D006918:Hydroxyurea